| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.37 | 3e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.2 | 6e-06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |